Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 68-74

  Paik, Jean Kyung ^a   Kim, Oh Yoen ^a,b   Koh, Soo Jeong ^a,b   Jang, Yangsoo ^b,c   Chae, Jey Sook ^a,b   Kim, Ji Young ^a,b,d   Kim, Hyae Jin ^a   Hyun, Yae Jung ^a,b   Cho, Jung Rae ^c   Lee, Jong Ho ^a,b  

^a Yonsei University   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d DNA Link Inc   (South Korea)

Author keywords

Cardiovascular disease risk; CRP SNPs; IL 6 572C > G; Insulin resistance; Serum CRP

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; LIPID;

ADULT; ALCOHOL CONSUMPTION; ALLELE; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; GENE INTERACTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREA; LIPID BLOOD LEVEL; MALE; METABOLIC DISORDER; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STATISTICAL ANALYSIS;

ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; KOREA; LIPIDS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 33947695600     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.11.011     Document Type: Article

References (39)

1. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
2. Trevelyan J., Brull D.J., Needham E.W., Montgomery H.E., Morris A., and Mattu R.K. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene. Am J Cardiol 94 (2004) 564-569
3. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 89 (2001) 763-771
4. Antonicelli R., Olivieri F., Bonafe M., et al. The interleukin-6-174G > C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int J Cardiol 103 (2005) 266-271
5. Ballou S.P., and Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 4 (1992) 361-368
6. Li J.J., and Fang C.H. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 62 (2004) 499-506
7. Kritchevsky S.B., Cesari M., and Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res 66 (2005) 265-275
8. Rao M., Jaber B.L., and Balakrishnan V.S. Inflammatory biomarkers and cardiovascular risk: association or cause and effect?. Semin Dial 19 (2006) 129-135
9. Andreotti F., Porto I., Crea F., and Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87 (2002) 107-112
10. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
11. Maier W., Altwegg L.A., Corti P., et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid about decreased C-reactive protein. Circulation 111 (2005) 1355-1361
12. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
13. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
14. Szalai A.J. The biological functions of C-reactive protein. Vasc Pharmacol 39 3 (2002) 105-107
15. Hak A.E., Stehouwer C.D., Bots M.L., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
16. Kim O.Y., Koh S.J., Jang Y., et al. Plasma adiponectin is related to other cardiovascular risk factors in nondiabetic Korean men with CAD, independent of adiposity and cigarette smoking: cross-sectional analysis. Clin Chim Acta 370 (2006) 63-71
17. Humphries S.E., Luong L.A., Ogg M.S., Hawe E., and Miller G.J. The interleukin-6-174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 2243-2252
18. Vickers M.A., Green F.R., Terry C., et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 53 (2002) 1029-1034
19. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
20. Basso F., Lowe G.D., Rumley A., McMahon A.D., and Humphries S.E. Interleukin-6-174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22 (2002) 599-604
21. Brull D.J., Serrano N., Zito F., et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol 23 (2003) 2063-2069
22. Ferrari S.L., Ahn-Luong L.P., Garnero S.E., and Humphries S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 255-259
23. Chen J., Zhao J., Huang J., Su S., Qiang B., and Gu D. -717A > G polymorphism of human C-reactive protein gene associated with coronary heart disease in ethnic Han Chinese: the Beijing Atherosclerosis Study. J Mol Med 83 (2005) 72-78
24. Latkovskis G., Licist N., and Kalnins U. C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease. Eur J Immunogenet 31 (2004) 207-213
25. Chiappelli M., Tampieri C., Tumini E., et al. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet 32 (2005) 349-353
26. Hamid Y.H., Rose C.S., Urhammer S.A., et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 48 (2005) 251-260
27. Kitamura A., Hasegawa G., Obayashi H., et al. Interleukin-6 polymorphism (- 634C/G) in the promotor region and the progression of diabetic nephropathy in Type-2 diabetes. Diabet Med 19 (2002) 1000-1005
28. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 8 (1990) 253-278
29. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
30. Kern P.A., Ranganathan S., Li C., Wood L., and Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280 (2001) E745-E751
31. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., and Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 9 (2001) 414-417
32. Pickup J.C., Chusney G.D., Thomas S.M., and Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in Type-2 diabetes. Life Sci 67 (2000) 291-300
33. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing Type-2 diabetes mellitus. JAMA 286 (2001) 327-334
34. Fernandez-Real J.M., Vayreda M., Richart C., et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 86 (2001) 1154-1159
35. Rexrode K.M., Pradhan A., Manson J.E., Buring J.E., and Ridker P.M. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol 13 (2003) 674-682
36. Senn J.J., Klover P.J., Nowak I.A., and Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
37. Kovacs A., Green F., Hansson L.O., et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178 (2005) 193-198
38. Zee R.Y., and Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 162 (2002) 217-219
39. D'Aiuto F., Casas J.P., Shah T., Humphries S.E., Hingorani A.D., and Tonetti M.S. C-reactive protein (+ 1444C > T) polymorphism influences CRP response following a moderate inflammatory stimulus. Atherosclerosis 179 (2005) 413-417